EPHX2 and Alzheimer disease: For instance, within the brain, enhancement of EET levels via inhibition of the EET inactivating enzyme soluble epoxide hydrolase (sEH) or administration of 14,15-EET dampens Alzheimer’s disease progression in a preclinical model20,21.